Jim Simons Rallybio Corp Put Options Transaction History
Renaissance Technologies LLC
- $62.3 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RLYB
# of Institutions
48Shares Held
32.4MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$1.51 Million0.01% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.64MShares$1.31 Million0.78% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$1.31 Million1.63% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$1.19 Million4.83% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$1.09 Million0.06% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $11.6M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...